Clinical trial

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

NCT00018057

Study summary

ClinicalTrials.gov

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BEHAVIORAL · Unmapped registry intervention Attention Bias Modification Training Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Fluoxetine Normalized identity: fluoxetine View linked drug · Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Cognitive Behavioral Therapy Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2001-10-02

PhasePHASE2

Conditions

Anxiety Disordersunresolved

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

Attention Bias Modification TrainingBEHAVIORAL

FluoxetineDRUG · verified · RxNorm: fluoxetine

Cognitive Behavioral TherapyBEHAVIORAL

Sponsors & collaborators

National Institute of Mental Health (NIMH)lead sponsor

Mapped research locations

BethesdaMaryland, United States1 College ParkMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00018057 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.